Halozyme Therapeutics Inc... (HALO)
NASDAQ: HALO
· Real-Time Price · USD
60.80
-0.62 (-1.01%)
At close: May 01, 2025, 2:57 PM
Halozyme Therapeutics Revenue
Halozyme Therapeutics reported an annual revenue of $1.02B, reflecting a 22.44% growth. For the quarter ending December 31, 2024, Halozyme Therapeutics generated $298.01M in revenue.
Revenue (ttm)
$1.02B
Revenue Growth
22.44%
Price / Sales Ratio
5.97
Revenue / Employee
$2.9M
Employees
350
Market Cap
7.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 1.02B | +22.44% |
| Dec 31, 2023 | 829.25M | +25.62% |
| Dec 31, 2022 | 660.12M | +48.91% |
| Dec 31, 2021 | 443.31M | +65.67% |
| Dec 31, 2020 | 267.59M | n/a |